Anabolic therapies for osteoporosis in postmenopausal women: effectiveness and value : final evidence report
- Collection:
- Health Policy and Services Research
- Contributor(s):
- California Technology Assessment Forum, issuing body. Institute for Clinical and Economic Review, issuing body.
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 17, 2017
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Anabolic Agents -- therapeutic use Antibodies, Monoclonal, Humanized -- therapeutic use Osteoporosis, Postmenopausal -- drug therapy Parathyroid Hormone-Related Protein -- therapeutic use Anabolic Agents -- adverse effects Anabolic Agents -- economics Antibodies, Monoclonal, Humanized -- adverse effects Antibodies, Monoclonal, Humanized -- economics Bone Density Conservation Agents -- adverse effects Bone Density Conservation Agents -- economics Bone Density Conservation Agents -- therapeutic use Comparative Effectiveness Research Diphosphonates -- adverse effects Diphosphonates -- economics Diphosphonates -- therapeutic use Osteoporotic Fractures -- prevention & control Parathyroid Hormone-Related Protein -- adverse effects Parathyroid Hormone-Related Protein -- economics Randomized Controlled Trials as Topic Teriparatide -- adverse effects Teriparatide -- economics Teriparatide -- therapeutic use Humans United States
- Genre(s):
- Technical Report
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
- 1 online resource (1 PDF file (v, ES21, 113 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 101723912 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101723912